Advertisement

Antimicrobial Agents

Chapter

Abstract

Though initially described by Alexander Fleming in the 1940s, there has only been a recent understanding of the development of antibacterial resistance and the role that is played by widespread antimicrobial overuse. This has spurred the development of new antimicrobials and mechanisms by which to counter microbial growth, which unfortunately has plateaued. As a result, special vigilance must now be paid to the appropriate use and timing of antimicrobials in an effort to maintain their efficacy.

Keywords

Clavulanic Acid Sputum Culture Positive Sputum Culture Surgical Antimicrobial Prophylaxis Surgical Antibiotic Prophylaxis 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Supplementary material

References

  1. 1.
    Ahdal OA, Bevan DR. Clindamycin-induced neuromuscular blockade. Can J Anaesth. 1995;42:614–7.PubMedCrossRefGoogle Scholar
  2. 2.
    Bratzler DW, Dellinger EP, Olsen KM, Perl TM, Auwaerter PG, Bolon MK, et al. Clinical practice guidelines for antimicrobial prophylaxis in surgery. Am J Health Syst Pharm. 2013;70(3):195–283. doi: 10.2146/ajhp120568.PubMedCrossRefGoogle Scholar
  3. 3.
    Bryson EO, Frost EA, Rosenblatt MA. Management of the patient reporting an allergy to penicillin. Middle East J Anesthesiol. 2007;19(3):495–512. Review.PubMedGoogle Scholar
  4. 4.
    Carr A, Cooper DA. Adverse effects of antiretroviral therapy. Lancet. 2000;356:1423–8.PubMedCrossRefGoogle Scholar
  5. 5.
    Davis RL, Smith AL, Koup JR. The “red-man’s syndrome” and slow infusion of vancomycin. N Engl J Med. 1985;313:756–7.CrossRefGoogle Scholar
  6. 6.
    Diekema DJ, Jones RN. Oxazolidinone antibiotics. Lancet. 2001;358:77–8.CrossRefGoogle Scholar
  7. 7.
    Hines RL, Marschall KE. Stoelting’s anesthesia and co-existing diseases. 6th ed. Pennsylvania: Elsevier Inc.; 2012.Google Scholar
  8. 8.
    Hooper DC, Wolfson JS. Fluoroquinolone antimicrobial agents. N Engl J Med. 1991;324:384–94.PubMedCrossRefGoogle Scholar
  9. 9.
    Kelkar PS, Li JT. Cephalosporin allergy. N Engl J Med. 2001;345:804–8.PubMedCrossRefGoogle Scholar
  10. 10.
    Levy JH, Kettlekamp N, Goertz P, et al. Histamine release by vancomycin. A mechanism for hypotension in man. Anesthesiology. 1987;67:122–5.PubMedCrossRefGoogle Scholar
  11. 11.
    Lin HC, Sanders SL, Gu YG, et al. Erythromycin accelerates solid emptying at the expense of gastric sieving. Dig Dis Sci. 1994;39:124–8.PubMedCrossRefGoogle Scholar
  12. 12.
    Linden P. Safety profile of meropenem: an updated review of over 6,000 patients treated with meropenem. Drug Saf. 2007;30(8):657–68.PubMedCrossRefGoogle Scholar
  13. 13.
    Mangram AJ, Horan TC, Pearson ML, Silver LC, Jarvis WR. Guideline for prevention of surgical site infection, 1999. Hospital Infection Control Practices Advisory Committee. Infect Control Hosp Epidemiol. 1999;20(4):250–78; quiz 279–80.PubMedCrossRefGoogle Scholar
  14. 14.
    Mayhew JF, Deutsch S. Cardiac arrest following administration of vancomycin. Can Anaesth Soc J. 1985;32:65–6.PubMedCrossRefGoogle Scholar
  15. 15.
    Mazze RI, Woodruff RE, Heerdt ME. Isoniazid-induced enflurane defluorination in humans. Anesthesiology. 1982;57:5–8.PubMedCrossRefGoogle Scholar
  16. 16.
    Morgan Jr GE, Mikhail MS, Murray MJ. Clinical anesthesiology. 4th ed. New York: McGraw-Hill Companies, Inc; 2006. Glucose intolerance.Google Scholar
  17. 17.
    Mori H, Takahashi K, Mizutani T. Interaction between valproic acid and carbapenem antibiotics. Drug Metab Rev. 2007;39(4):647–57.PubMedCrossRefGoogle Scholar
  18. 18.
    Muto CA, Jernigan JA, Ostrowsky BE, Richet HM, Jarvis WR, Boyce JM, Farr BM. SHEA guideline for preventing nosocomial transmission of multidrug-resistant strains of Staphylococcus aureus and enterococcus. Infect Control Hosp Epidemiol. 2003;24(5):362–86.PubMedCrossRefGoogle Scholar
  19. 19.
    Ray WA, Murray KT, Meredith S, Narasimhulu SS, Hall K, Stein CM. Oral erythromycin and the risk of sudden death from cardiac causes. N Engl J Med. 2004;351:1089–96.PubMedCrossRefGoogle Scholar
  20. 20.
    Spellberg B, Bartlett JG, Gilbert DN. The future of antibiotics and resistance. N Engl J Med. 2013;368(4):299–302.PubMedCentralPubMedCrossRefGoogle Scholar
  21. 21.
    Tanne JH. FDA adds “black box” warning to fluoroquinolone antibiotics. BMJ. 2008;337:a816.PubMedCrossRefGoogle Scholar
  22. 22.
    US Department of Health and Human Services. Initial therapy for tuberculosis in the era of multidrug resistance: recommendations of the Advisory Council for the Elimination of Tuberculosis. MMWR Morb Mortal Wkly Rep. 1993;42:1–7.Google Scholar
  23. 23.
    US Department of Health and Human Services. Panel on antiretroviral guidelines for adults and adolescents. Available at http://aidsinfo.nih.gov/ContentFiles/AdultandAdolescentGL.pdf. Section accessed 16 Mar 2013.

Copyright information

© Springer Science+Business Media New York 2015

Authors and Affiliations

  • Rebecca Johnson
    • 1
  • Richard Lancaster
    • 1
  • Timothy Ku
    • 1
  1. 1.Department of AnesthesiologyTulane Medical CenterNew OrleansUSA

Personalised recommendations